Symbol="ARQT"
AssetType="Common Stock"
Name="Arcutis BiotherapeuticsÂ Inc"
Description="Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California."
CIK="1787306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2945 TOWNSGATE ROAD, SUITE 110, WESTLAKE VILLAGE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="588426000"
EBITDA="-314116992"
PERatio="None"
PEGRatio="None"
BookValue="2.277"
DividendPerShare="0"
DividendYield="0"
EPS="-5.81"
RevenuePerShareTTM="0.112"
ProfitMargin="0"
OperatingMarginTTM="-48.75"
ReturnOnAssetsTTM="-0.53"
ReturnOnEquityTTM="-1.663"
RevenueTTM="6467000"
GrossProfitTTM="2932000"
DilutedEPSTTM="-5.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="44.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1385.79"
PriceToBookRatio="3.742"
EVToRevenue="1017.85"
EVToEBITDA="-2.448"
Beta="0.601"
num_52WeekHigh="27.4"
num_52WeekLow="7.25"
num_50DayMovingAverage="9.54"
num_200DayMovingAverage="13.53"
SharesOutstanding="61422000"
DividendDate="None"
ExDividendDate="None"
symbol="ARQT"
open="9.53"
high="9.97"
low="9.44"
price="9.83"
volume="816089.00"
latest_trading_day="2023-08-08"
previous_close="9.58"
change="0.25"
change_percent="2.6096%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1162084"
Change_recent_avg="-0.01"
Delta_recent_avg="0.74"
Variance_recent_avg="0.37"
Change_ratio_recent_avg="-0.23"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="644"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_positive_thumbnail_id_2="955"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
